- Home
- AIMD vs USEA Comparison
AIMD vs USEA Comparison
Compare AIMD & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- USEA
- Stock Information
- Founded
- AIMD 1984
- USEA 2004
- Country
- AIMD United States
- USEA Greece
- Employees
- AIMD N/A
- USEA N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- AIMD Health Care
- USEA Consumer Discretionary
- Exchange
- AIMD Nasdaq
- USEA Nasdaq
- Market Cap
- AIMD 11.9M
- USEA 10.5M
- IPO Year
- AIMD N/A
- USEA N/A
- Fundamental
- Price
- AIMD $2.33
- USEA $1.57
- Analyst Decision
- AIMD
- USEA
- Analyst Count
- AIMD 0
- USEA 0
- Target Price
- AIMD N/A
- USEA N/A
- AVG Volume (30 Days)
- AIMD 134.7K
- USEA 23.2K
- Earning Date
- AIMD 08-15-2025
- USEA 08-06-2025
- Dividend Yield
- AIMD N/A
- USEA 2.55%
- EPS Growth
- AIMD N/A
- USEA N/A
- EPS
- AIMD N/A
- USEA N/A
- Revenue
- AIMD $106,207.00
- USEA $42,595,000.00
- Revenue This Year
- AIMD N/A
- USEA N/A
- Revenue Next Year
- AIMD N/A
- USEA $11.62
- P/E Ratio
- AIMD N/A
- USEA N/A
- Revenue Growth
- AIMD 13.38
- USEA N/A
- 52 Week Low
- AIMD $2.00
- USEA $1.00
- 52 Week High
- AIMD $5.00
- USEA $2.78
- Technical
- Relative Strength Index (RSI)
- AIMD 36.64
- USEA 54.34
- Support Level
- AIMD $2.40
- USEA $1.50
- Resistance Level
- AIMD $2.66
- USEA $1.61
- Average True Range (ATR)
- AIMD 0.19
- USEA 0.07
- MACD
- AIMD -0.04
- USEA -0.01
- Stochastic Oscillator
- AIMD 11.77
- USEA 73.68
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.